Author:
Patil Anjali D.,Patil Deepak S.,Shinde Anjali R.,Shinde Ravindra V.,Shinde Sandeep B.
Abstract
BACKGROUND Dacryocystitis is one of the most frequent diseases of the efferent lacrimal system. It is the infection or inflammation of the lacrimal sac. This is usually because of nasolacrimal duct obstruction. Acute dacryocystitis can cause severe morbidity and rarely mortality in patients. This study wanted to identify the aerobic bacterial aetiology, and demonstrate the antibiogram of bacterial isolates of acute dacryocystitis. METHODS A retrospective record-based study was conducted in Rural Tertiary Healthcare Centre. Clinical Data of 89 patients was collected from medical records of 2014 to 2018 documents. Data of bacterial isolates and their antibiogram were retrieved from records in the Department of Microbiology. RESULTS The most common aerobic Gram-positive bacteria were Staphylococcus aureus (29.8 %) and Coagulase Negative staphylococcus (23.3 %). The most common Gramnegative bacteria were pseudomonas spp. (19.4 %) and klebsiella spp. (12.9 %). CONCLUSIONS The knowledge of bacterial profile in different geographic region, different age group will help to develop and implement treatment protocol. KEY WORDS Acute Dacryocystitis, Bacterial Profile, Antibiogram
Publisher
Akshantala Enterprises Private Limited
Reference11 articles.
1. Microbial flora of dacryocystitis and its antibiogram;Jawaid;Int J Curr Microbiol App Sci,2017
2. [2] Shah CP, Santani D. A comparative bacteriological profile and antibiogram of dacryocystitis. Nepal J Ophthalmol 2011;3(2):134-9.
3. [3] Badhu BP, Karki BS, Khanal B, et al. Microbiological patterns ofchronic dacryocystitis. Ophthalmology 2006;113(12):2377.e1-2.
4. [4] Kebede A, Adamu Y, Bejiga A. Bacteriological study of dacryocystitis among patients attending in Menelik II Hospital, Addis Ababa, Ethiopia. Ethiop Med J 2010;48(1):29-33.
5. [5] Mandal R, Banerjee AR, Biswas MC, et al. Clinicobacteriological study of chronic dacryocystitis in adults. J Indian Med Assoc 2008;106(5):296-8.